Galvin, Gaustad & Stein, LLC has filed its 13F form on January 23, 2026 for Q4 2025 where it was disclosed a total value porftolio of $1.21 Billion distributed in 250 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Tr with a value of $40M, Vanguard Ftse Developed Market with a value of $35.8M, Microsoft Corp with a value of $35.7M, Hca Healthcare, Inc. with a value of $31.8M, and Jpmorgan Chase & CO with a value of $30.9M.

Examining the 13F form we can see an increase of $55.2M in the current position value, from $1.15B to 1.21B.

Below you can find more details about Galvin, Gaustad & Stein, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.21 Billion
ETFs: $530 Million
Technology: $152 Million
Financial Services: $120 Million
Consumer Cyclical: $101 Million
Healthcare: $84.7 Million
Industrials: $77.2 Million
Consumer Defensive: $44.6 Million
Communication Services: $43.1 Million
Other: $52.5 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 250
  • Current Value $1.21 Billion
  • Prior Value $1.15 Billion
  • Filing
  • Period Q4 2025
  • Filing Date January 23, 2026
  • Form Type 13F-HR
  • Activity in Q4 2025
  • New Purchases 53 stocks
  • Additional Purchases 95 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 79 stocks
Track This Portfolio

Track Galvin, Gaustad & Stein, LLC Portfolio

Follow Galvin, Gaustad & Stein, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.